Ochsner Health System and Pfizer have entered into a multi-year strategic alliance to develop innovative models for clinical trials. Through this partnership, Pfizer and Ochsner – through its innovation lab, innovationOchsner, in partnership with Ochsner Research – will explore ways to enhance the clinical trial experience and ease participation in clinical research for both patients and healthcare professionals.The alliance aims to create faster, improved access and connectivity to clinical trials for patients, with the ultimate goal of better experiences and outcomes. Participating patients will have the opportunity to test out new digital tools designed to make the clinical trial experience more inclusive and enjoyable. Participating clinicians will benefit from reduced manual data entry as a result of direct data system integration and automated study conduct tools. The strategic alliance’s first project began with a “proof of value” phase in which researchers successfully transferred mock data from Ochsner’s EHR system to Pfizer’s electronic data capture system used in Pfizer clinical trials. The experiment aimed at understanding the gaps and variances between data collected in electronic health records and patient-reported data from clinical trials. During the next phase, Pfizer and Ochsner will continue to develop new ways to digitize the patient and clinician experience in clinical trials, with attention to patient preferences on access to and use of their health data and with an overarching goal of enhancing the quality and value of clinical research interactions for all participants.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.